Important Resources · Mind Medicine Australia
Mind Medicine Australia logo Menu

Important Resources

Documents

Mind Medicine Australia Overview

Pioneering a new paradigm for mental health treatment in Australia.

Download (228.7 KB)

Mind Medicine Australia FAQ

Frequently Asked Questions about Mind Medicine Australia and psychedelics.

Download (628.4 KB)

What is Psychedelic-Assisted Therapy?

This paper outlines the therapeutic process of psychedelic-assisted therapy and describes the three distinct therapy phases: preparation, the experience and integration.

Download (167.3 KB)

Mental Health Statistics

Some basic numbers relevant to mental illness in Australia

Download (105.3 KB)

Mind Medicine Australia Psychological Support Services Brochure

Overview of services involve assessment, therapy, group work integration, professional education, training and supervision.

Download (143.8 KB)

Certificate in Psychedelic-Assisted Therapies FAQ

Frequently asked questions about our Certificate in Psychedelic-Assisted Therapies (CPAT).

Download (194.0 KB)

Mind Medicine Australia Fact Sheet

A 2 page infographic outlining key facts and figures about mental health and Mind Medicine Australia.

Download (1.7 MB)

Mind Medicine Australia Ebook

A compilation of our mission, an overview of the mental illness crisis and frequently asked questions.

Download (3.4 MB)

International Summit on Psychedelic Therapies for Mental Illness

A two-day International Summit on Psychedelic Therapies for Mental Illness in November 2021 in Melbourne.

Download (211.4 KB)

Psychedelic Medical Research

A Review of Recent Developments and the status of recent and current research trials involving psychedelics listed by the World Health Organisation.

Download (371.6 KB)

List of Drug/Substances and their negative and positive effects

Here's a list outlining the negative and positive effects of each drug subclass.

Download (173.9 KB)

Interactions with other Medicines

Psilocybin and interactions with other medicines.

Download (130.4 KB)

Antidepressant & Psychedelic Drug Interaction Chart

This table outlines the time period required to reduce the intake of antidepressants before administering a psychedelic, in order to maximise its effect.

Download (506.4 KB)

List of Legal Psychedelic Medicine Centers

Here's a list of legal psychedelic retreat providers and psychedelic therapy centers overseas

Download (414.5 KB)

List of Educational Books and Videos

A collection of books and videos to learn all about psychedelics.

Download (403.6 KB)

Psychedelic Substances Table

An overview of psychedelic substances scheduling in different countries.

Download (163.4 KB)

Psychedelic Timeline

A timeline showing the use of plant medicines from ~5000 BCE to the present.

A timeline showing the use of plant medicines

Covid-19 Significant Societal and Mental Health Impacts

Mind Medicine Australia has put together a report documenting Covid-19 Significant Societal and Mental Health Impacts. The report includes: Modelling and Future Predictions, Children and Youth, Mental Health, Unemployment, Domestic and Family Violence, Divorce, Alcohol and Tobacco, Financial Insecurity, Eating Disorders, Refugee and Migrant Issues, Social Media, Hospitalisations and Emergency Department, Crime and Cyber Abuse, Racism, Porn Use

Download (434.2 KB)

Mystical Experiences Questionnaire

.

Download (550.7 KB)

Relative Drug Harms

A study comparing relative drug harms of various substances.

Download (322.0 KB)

FMRI scans comparing psilocybin with the placebo for depression

Increased communication between brain networks shown on fMRI scans.

Download (650.2 KB)

Application of MDMA in PTSD Psychotherapy

Source: Multidisciplinary Association for Psychedelic Studies (MAPS)

Download (315.5 KB)

Mind Medicine Australia TGA Rescheduling Submissions

Mind Medicine Australia Submission Guide

Mind Medicine Australia's overview and instruction on how to make your submission to the TGA.

Download (785.5 KB)

Medicinal Psilocybin Rescheduling Application

Mind Medicine Australia's application to reschedule Psilocybine from Schedule 9 to Schedule 8 of the Poisons Standard 14 July 2020.

Download (2.2 MB)

Medicinal MDMA Rescheduling Application

Mind Medicine Australia's application to reschedule N, α-DIMETHYL 3,4(METHYLENEDIOXY) PHENYLETHYLAME (MDMA) from Schedule 9 to Schedule 8 of the Poisons Standard 15 July 2020.

Download (1.8 MB)

Drug Science Educational Slides Medicinal Psilocybin Educational Slides

Module 1 – History & Current Law

Despite the promising research emanating from prestigious universities such as Imperial College London and Johns Hopkins University (Maryland), psilocybin is still a Schedule 1 substance. This means that research into this psychotropic is expensive, laborious and time-consuming. The current legal regime has curtailed our scientific understanding of this substance for 30 years, however, the law relating to psilocybin is not fit for purpose due to the exceptional safety profile of this drug and it’s potential for therapeutic application.

Download (10.8 MB)

Module 2 – Pharmacology

Module 2 takes a deep dive into the neurology and pharmacology that underpins medicinal psilocybin. This slide set explains how psilocybin operates in the human body, its interactions with the brain, the biosynthesis process and metabolism. Understanding the psychoactive properties and physiological effects of psilocybin is vitally important for medical students regardless of this drug’s legal status. Psilocybin has therapeutic applications but it also has associated risks and adverse events, being aware of all of these relevant factors will help inform the next generation of psychotherapists and researchers.

Download (44.7 MB)

Medicinal MDMA Educational Slides

Module 1 – History & Current Law

Module 1 focuses on the historical use of MDMA, internationally and in the UK. This includes a chronological look at the prohibition of MDMA, it’s use recreationally and why it was banned in the first place. Module 1 will also examine the current legal status of MDMA internationally, the potential harms of this drug and the ways to mitigate those harms. MDMA studies are underwritten by the Food and Drug Administration (FDA) classification of Breakthrough Therapy status, potentially resulting in FDA and European Medicines Agency (EMA) approval of MDMA-assisted therapy for clinical implementation in the USA and the EU. Our goal in this module is to educate medical students on this substance to prepare them for the integration of this substance into western medicine.

Download (15.9 MB)

Module 2 – Pharmacology

Module 2 takes a deep dive into the neurology and pharmacology that underpins MDMA. This slide set explains how MDMA operates in the human body, its interactions with the brain, the biosynthesis process and metabolism. Understanding the psychoactive properties and physiological effects of MDMA is vitally important for medical students regardless of this drug’s legal status. MDMA has therapeutic applications but it also has associated risks and adverse events, being aware of all of these relevant factors will help inform the next generation of psychotherapists and researchers.

Download (29.5 MB)

Medicinal N,N-dimethyltryptamine (DMT) Educational Slides

Module 1 – History & Current Law

The psychedelic compound dimethyltryptamine (DMT), sometimes referred to as ‘the spirit molecule’, is prevalent in plants and animals, including humans, and has been used as a sacred entheogen for thousands of years by many indigenous communities. Now, recent research has shown the molecule could have benefits for conditions such as depression, anxiety, and PTSD, and could potentially offer a fast-acting treatment for resistant depression.

Learn more

Module 2 – Pharmacology

Module 2 takes a deep dive into the neurology and pharmacology that underpins DMT.

Learn more

Download and Print - Meet With Your GP!

1. Mind Medicine Australia SAS-B TGA Application Form

Mind Medicine Australia SAS-B TGA Application Form

Download (124.3 KB)

2. Mind Medicine Australia MDMA SAS-B Cover Letter Example

Mind Medicine Australia MDMA SAS-B Cover Letter Example

Download (100.1 KB)

3. Mind Medicine Australia MDMA SAS-B Proforma Template

Mind Medicine Australia MDMA SAS-B Proforma Template

Download (1.1 MB)

4. Mind Medicine Australia MDMA SAS-B Patient Information Form

Mind Medicine Australia MDMA SAS-B Patient Information Form

Download (25.2 KB)

5. Mind Medicine Australia Psilocybin SAS-B Cover Letter Example

Mind Medicine Australia Psilocybin SAS-B Cover Letter Example

Download (504.6 KB)

6. Mind Medicine Australia Psilocybin SAS-B Proforma Template

Mind Medicine Australia Psilocybin SAS-B Proforma Template

Download (648.2 KB)

7. Mind Medicine Australia Psilocybin SAS-B Patient Information Form

Mind Medicine Australia Psilocybin SAS-B Patient Information Form

Download (102.6 KB)

Mind Medicine Australia Branding

Logos

MMA logo in various formats

Download (151.4 KB)

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×